| |
2006*
Rm |
2005*
Rm |
2004**
Rm |
2003**
Rm |
2002**
Rm |
| Summarised
group income statement |
|
|
|
|
|
| Income from operations
|
5 369 |
4 858 |
4 404 |
4 543 |
3 986 |
| Other income |
71 |
107 |
133 |
454 |
373 |
| Total income |
5 440 |
4 965 |
4 537 |
4 997 |
4 359 |
| Operating expenses |
(5 094) |
(4 229) |
(3 684) |
(4 291) |
(3 514) |
| Operating profit |
346 |
736 |
853 |
706 |
845 |
| |
|
|
|
|
|
| Analysed as follows:
|
|
|
|
|
|
| Trading results
of operations |
791 |
772 |
775 |
805 |
638 |
| Profit from direct marketing
entity in run-off |
41 |
68 |
99 |
160 |
140 |
Consolidation of group
cell captive insurance
arrangement |
(1) |
23 |
- |
- |
- |
| Impairment charges and
other capital items |
(19) |
(21) |
(27) |
- |
- |
| Goodwill amortisation
and other capital items |
- |
- |
- |
(144) |
(90) |
| Exceptional gains and
losses |
(466) |
(106) |
6 |
(115) |
157 |
| Operating profit |
346 |
736 |
853 |
706 |
845 |
| Net interest (costs)/income |
(5) |
(63) |
(172) |
(117) |
(65) |
| Interest
and investment income |
87 |
54 |
79 |
110 |
130 |
| Finance
costs |
(92) |
(117) |
(251) |
(227) |
(195) |
Net fair value gain (offset
by taxation expense
attributable to policyholders) |
18 |
9 |
- |
- |
- |
Effect of accounting for
policyholder investments
as treasury shares under IFRS |
(81) |
(30) |
- |
- |
- |
| Share of net profits
of associates |
17 |
5 |
9 |
29 |
61 |
| Profit before
taxation |
295 |
657 |
690 |
618 |
841 |
| Taxation |
|
|
|
|
|
| –
Taxation expense |
(220) |
(190) |
(211) |
(221) |
(315) |
| –
Taxation attributable to policyholders'
funds |
(18) |
(9) |
|
|
|
| Profit for
the year |
57 |
458 |
479 |
397 |
526 |
| |
|
|
|
|
|
| Attributable
to: |
|
|
|
|
|
| –
Ordinary shareholders |
12 |
413 |
439 |
322 |
448 |
| –
Minority interests |
45 |
45 |
40 |
75 |
78 |
| Profit for
the year |
57 |
458 |
479 |
397 |
526 |
| |
|
|
|
|
|
| Reconciliation
to headline earnings: |
|
|
|
|
|
| Profit attributable to
ordinary shareholders |
12 |
413 |
439 |
322 |
448 |
| Adjusted
for: |
|
|
|
|
|
| –
Impairment charges and other capital items |
19 |
21 |
27 |
144 |
90 |
| –
Share of headline adjusting items of associates |
(14) |
2 |
|
|
|
| –
Less: taxation and minority interest
thereon |
- |
- |
(1) |
- |
(5) |
| |
|
|
|
|
|
Headline earnings
attributable to ordinary
shareholders |
17 |
436 |
465 |
466 |
533 |
| Adjusted
for: |
|
|
|
|
|
| –
Profit from direct marketing entity in run-off |
(41) |
(68) |
(99) |
(160) |
(140) |
| –
Exceptional gains and losses |
466 |
106 |
(6) |
115 |
(157) |
–
Loss arising from accounting for policyholder
investments as treasury
shares under IFRS |
81 |
30 |
- |
- |
- |
| –
Reversal of interest effects of exchangeable
bonds |
- |
38 |
126 |
139 |
121 |
| –
Tax effects on above items |
13 |
(23) |
(6) |
(31) |
53 |
Core earnings
attributable to ordinary
shareholders |
536 |
519 |
480 |
529 |
410 |
| |
|
|
|
|
|
| Summarised
group balance sheet |
|
|
|
|
|
| Ordinary shareholders'
funds |
1 531 |
1 995 |
1 140 |
950 |
756 |
| Minority interests |
82 |
102 |
107 |
120 |
222 |
Financial liabilities
of investment contracts,
cell captive insurance facilities and housing
loans |
124 098 |
89
329 |
64
890 |
46
302 |
44
982 |
| Borrowings |
678 |
760 |
1 829 |
2 503 |
2 153 |
| Retirement benefit obligations |
236 |
308 |
170 |
187 |
285 |
| Deferred tax liabilities |
95 |
55 |
3 |
1 |
29 |
| Deferred consideration
for acquisitions |
191 |
187 |
120 |
- |
- |
| Provisions |
680 |
176 |
71 |
98 |
123 |
| Other liabilities |
3 519 |
3 628 |
3 426 |
3 893 |
6 253 |
| Total equity and liabilities |
131 110 |
96 540 |
71 756 |
54 054 |
54 803 |
Financial assets of investment
contracts,
cell captive insurance facilities and housing
loans |
123 852 |
89
156 |
64
890 |
46
302 |
44
982 |
| Property, equipment and
software |
251 |
290 |
289 |
241 |
231 |
| Goodwill and other intangibles |
2 139 |
2 193 |
2 002 |
1 929 |
1 315 |
| Other assets |
2 065 |
2 273 |
2 438 |
3 187 |
4 441 |
| Cash and cash equivalents |
2 803 |
2 628 |
2 137 |
2 395 |
3 834 |
| Total assets |
131 110 |
96 540 |
71 756 |
54 054 |
54 803 |
| |
|
|
|
|
|
| Summarised
cash flow statement |
|
|
|
|
|
| Cash from trading operations |
958 |
931 |
934 |
1 115 |
984 |
| Cash from direct marketing
entity in run-off |
41 |
68 |
- |
- |
- |
| Movement in working capital
and insurance balances |
243 |
76 |
(184) |
(878) |
(55) |
| Taxation and distributions
to shareholders |
(449) |
(466) |
(439) |
(598) |
(339) |
| Cash flows from investing
activities |
(931) |
(198) |
(171) |
(1 267) |
(649) |
| Cash flows from financing
activities |
453 |
(123) |
(197) |
793 |
279 |
| Net cash flows |
315 |
288 |
(57) |
(835) |
220 |
| Foreign subsidiary translation
adjustment |
(140) |
(16) |
(201) |
(604) |
928 |
| Net movement in cash
balances |
175 |
272 |
(258) |
(1 439) |
1 148 |
| |
|
|
|
|
|
| Ordinary
share performance |
|
|
|
|
|
| Earnings per share |
|
|
|
|
|
| –
basic earnings (cents) |
3 |
105 |
127 |
94 |
131 |
| –
headline earnings (cents) |
4 |
111 |
135 |
136 |
156 |
| –
core earnings (cents) |
116 |
113 |
139 |
155 |
120 |
| Diluted earnings per share |
|
|
|
|
|
| –
basic earnings (cents) |
3 |
104 |
127 |
93 |
126 |
| –
headline earnings (cents) |
4 |
110 |
134 |
134 |
150 |
| Proposed distribution
per share (cents) |
59 |
67 |
67 |
67 |
61 |
| Dividend cover (times) |
2,0 |
2,0 |
2,0 |
2,0 |
2,6 |
| Dividend yield (%) |
3,9% |
5,9% |
6,6% |
6,5% |
4,7% |
| Share price (R) |
|
|
|
|
|
| –
average |
13,71 |
10,81 |
11,24 |
13,59 |
15,47 |
| –
closing |
14,95 |
11,40 |
10,20 |
10,35 |
13,10 |
| Number of shares in issue |
|
|
|
|
|
| –
issued (net of treasury shares) (millions) |
443 |
445 |
345 |
345 |
343 |
| –
weighted average (millions) |
443 |
394 |
345 |
342 |
342 |
| –
diluted weighted average (millions) |
447 |
396 |
347 |
347 |
356 |
| Net asset value per share
(cents) |
364 |
532 |
361 |
313 |
286 |
| Adjusted net asset value
per share (cents) |
389 |
552 |
361 |
313 |
286 |
| |
|
|
|
|
|
| Profitability
|
|
|
|
|
|
| Trading margin (%) |
15 |
16 |
18 |
18 |
16 |
| Effective rate of taxation
(%) |
27 |
27 |
29 |
29 |
34 |
| Return on average equity
(%) |
|
|
|
|
|
| –
core earnings |
15 |
16 |
17 |
24 |
13 |
| Foreign
subsidiaries translation rate (R : £1)
|
|
|
|
|
|
| Weighted average rate |
11,3 |
11,5 |
12,1 |
14,7 |
14,3 |
| Closing rate |
10,8 |
11,7 |
11,6 |
12,5 |
16,2 |
| Liquidity
and gearing |
|
|
|
|
|
| Interest cover (times) |
158 |
12 |
5 |
7 |
10 |
| Gearing level (%) |
38 |
34 |
160 |
263 |
285 |
| Current ratio (times) |
0,8 |
1,3 |
1,2 |
1,2 |
1,1 |
| Employees
|
|
|
|
|
|
| Number of employees
(excluding associates) |
5 771 |
5 714 |
5 495 |
5 420 |
5 363 |